The toxicity profile of non-selective FGFR inhibitors is similar to that of VEGFR TKIs, which include fatigue, anorexia, pyrexia, diarrhea, arthralgia, liver toxicity, hypertension, proteinuria, thrombotic microangiopathy, and hypothyroidism. This evidence concerns the gene KDR and Fever.